Michel Héaulme

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.7K citations · Full text

Pharmacotherapy, Experimental Pharmacology, Cannabinoid Pharmacology +18

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

D. Gully, M. Canton, Robert Boigegrain et al. · Proceedings of the National Academy of Sciences · 1993 · 413 citations

Neurotensin Receptor, Pharmacotherapy, Social Sciences +19

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

Xavier Emonds‐Alt, Jean-Daniel Doutremepuich, Michel Héaulme et al. · European Journal of Pharmacology · 1993 · 373 citations

Signal Transduction, Vivo Biological Activities, Medicine +8

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · Life Sciences · 1995 · 300 citations

Cannabis Use, Molecular Pharmacology, Functional Selectivity +14

SR 142801, The first potent non-peptide antagonist of the tachykinin NK3 receptor

Xavier Emonds‐Alt, Daniel Bichon, Jean-Philippe Ducoux et al. · Life Sciences · 1994 · 219 citations · Full text

Molecular Pharmacology, Tachykinin Nk3 Receptor, Signal Transduction +13